US 8871810
Treating critically ill patients with intravenous ibuprofen
granted A61KA61K31/192A61K31/197
Quick answer
US patent 8871810 (Treating critically ill patients with intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/192, A61K31/197, A61K45/06, A61K9/0019